Figures & data
Table 1 Baseline characteristics
Figure 1 Kaplan–Meier analysis showing that survival is greater following LVRS than following transplantation (p = 0.01) by the log-rank test.
![Figure 1 Kaplan–Meier analysis showing that survival is greater following LVRS than following transplantation (p = 0.01) by the log-rank test.](/cms/asset/ba28b0f2-5cdb-4be0-872d-290e0b1185c6/icop_a_216796_uf0001_b.gif)
Table 2 1-year postoperative data of surviving patients
Figure 2 Compares the changes in FEV1, 6-minute walk test, mBODE and Borg from before surgery to 1-year post-surgery between LVRS patients (shown on the left) and transplantation patients (shown on the right). More transplantation patients are missing or dead at 1-year (below dotted line), while more LVRS patients did not improve following surgery (also below dotted line). Of patients who survived 1 year post-surgery, the transplantation patients had greater improvements in functional status (above dotted line).
![Figure 2 Compares the changes in FEV1, 6-minute walk test, mBODE and Borg from before surgery to 1-year post-surgery between LVRS patients (shown on the left) and transplantation patients (shown on the right). More transplantation patients are missing or dead at 1-year (below dotted line), while more LVRS patients did not improve following surgery (also below dotted line). Of patients who survived 1 year post-surgery, the transplantation patients had greater improvements in functional status (above dotted line).](/cms/asset/0ebbc5a6-6ae8-49bf-a390-c4f87ae68d41/icop_a_216796_uf0002_b.gif)
Table 3 Secondary outcomes
Figure 3 Causes of death in transplantation patients included complications from immunosuppression, medications, and acute and chronic graft failure.
![Figure 3 Causes of death in transplantation patients included complications from immunosuppression, medications, and acute and chronic graft failure.](/cms/asset/167515e6-68d5-4abc-81db-928887a26955/icop_a_216796_uf0003_b.gif)
Figure 4 Kaplan–Meier analysis showing that survival is greater following LVRS than following transplantation in patients with baseline FEV1 20–30% at all times with a p = 0.04 by the log-rank test.
![Figure 4 Kaplan–Meier analysis showing that survival is greater following LVRS than following transplantation in patients with baseline FEV1 20–30% at all times with a p = 0.04 by the log-rank test.](/cms/asset/3802a22a-0d08-4578-ad7c-0e5651bbbec7/icop_a_216796_uf0004_b.gif)
Figure 5 Compares changes in FEV1, 6-minute walk distance, mBODE and Borg from before surgery to 1-year post-surgery between LVRS (shown on the left) and transplantation patients (shown on the right) with a baseline FEV1 20–30%. More transplantation patients are missing or dead at 1-year (below dotted line). While no LVRS patients died within 1 year following surgery, more did not improve following surgery (also below dotted line). Of patients who survived 1 year post-surgery, the transplantation patients had greater improvements in functional status (above dotted line).
![Figure 5 Compares changes in FEV1, 6-minute walk distance, mBODE and Borg from before surgery to 1-year post-surgery between LVRS (shown on the left) and transplantation patients (shown on the right) with a baseline FEV1 20–30%. More transplantation patients are missing or dead at 1-year (below dotted line). While no LVRS patients died within 1 year following surgery, more did not improve following surgery (also below dotted line). Of patients who survived 1 year post-surgery, the transplantation patients had greater improvements in functional status (above dotted line).](/cms/asset/5afd0ebe-c604-4de2-a1e9-11fca96b2ac6/icop_a_216796_uf0005_b.gif)